News

WHO approves India COVID vaccine for emergency use

Add Ticker News on Google

The World Health Organization has granted approval for emergency use to India’s government-backed Covid-19 vaccine, Covaxin

India’s vaccine was approved for use within India back in January while the third phase of clinical trials was still under way, sparking some concern and criticism.

The company that produces the vaccine, Bharat Biotech, has since published data suggesting 78% efficacy against the COVID-19 vaccine.

The WHO stated in a tweet it believed the benefits far outweighed the risks associated with the jab

“200 percent safe”

Some experts had pointed to a fast-track approval and incomplete data, but the firm’s chairman, Dr Krishna Ella, stated the vaccine was “200% safe”.

The expert panel World Health Organizations, which authorises emergency approvals, had asked for more data last month while examining the application Bharat Biotech had filed in July.

The approval comes as a major relief to the tens of millions of Indians who have already received the jab.

India has administered more than 105 million Covaxin doses so far – and a fillip for Bharat Biotech.

Few countries have recognised Covaxin and India hopes the WHO approval will change that.

How that will play out on travel restrictions for vaccinated Indians remains unclear.

Covishield is basically the Indian-made version of Astrazeneca and remains the most popular jab in the country, accounting for most of India’s 810 million jabs.

The vaccine has been approved by the WHO but the UK recognised the jab only after a refusal to do so sparked anger in India.

More on this story

Up next
Khawaja reignites sandpaper scandal debate

Usman Khawaja’s autobiography is reigniting debate over the media’s coverage of Australian cricket’s infamous sandpaper scandal.

Read the story →

Comments

No comments yet. Start the conversation.

Comments are checked before they appear. Keep it civil, and please don't make claims about people you can't back up.

Ticker Today takes a daily view of the world of news, politics and business.With Ahron YoungWhisky & Suits explores law, property finance and business over fine whisky.With Imran Khan and Chris ChristofiThe Founders Method explores practical lessons and systems for entrepreneursWith Jonathan Byrt and Jesse LeeworthyThe Connector explores property and urban growth across Australia and the UK.With Belinda CoateThe Property Playbook delivers research-led insights for property investors.With Tim Graham and Terry RyderState of Hospitality explores the challenges facing Australia's hospitality.With Jeremy KoadlowBuying Power helps young professionals enter property and build lasting wealth.With Victor and Reshmi KumarThe Airport Economist explores global trade, business and economic outlooks.With Tim HarcourtMedia Movers explores the trends shaping Australia's media and global news.With James ManningBroker Business explores strategies to build, grow and sustain a business.With Rex AfrasiabiMoney Matters explores practical financial strategies to build lasting wealth.With Dr Steven EnticottBeyond Education explores the ideas and technology shaping future learning.With Greg CampitelliTicker Air explores the latest aviation news, travel trends and developments.With Ahron YoungEarly Years Dialogue explores the issues shaping Australia's early learning.With Paul MondoMarkets and Machines explores AI, regulation and trends shaping the markets.With Chris BergSocial Intelligence explores how social media and AI transform our daily lives.With Dr Karen SutherlandThe AI Edge explores how artificial intelligence reshapes the world economy.With Brad Gastwirth

More from Ticker

Watch

More in News

View all →